Tenax Therapeutics
- Pharmaceutical Preparations
- Chapel Hill, North Carolina
Compensation history
Top executives at Tenax Therapeutics received an average of $832K per person in annual compensation from 2010 to 2023.
Average pay of disclosed executives at Tenax Therapeutics
By year
Executives
We found nine executives who work or worked at Tenax Therapeutics.
Christopher Giordano
Tenax Therapeutics
Chief Executive Officer
Stuart Rich
Tenax Therapeutics
Chief Medical Officer
Eliot Lurier
Tenax Therapeutics
Chief Financial Officer
Anthony DiTonno
Tenax Therapeutics
Chief Executive Officer
Michael Jebsen
Tenax Therapeutics
Chief Financial Officer
John Kelley
Tenax Therapeutics
Chief Executive Officer
Chris Stern
Tenax Therapeutics
Chief Executive Officer
Gerald Klein
Tenax Therapeutics
Chief Medical Officer
News
Tenax Therapeutics CEO Christopher Giordano's 2023 pay slips 3% to $645K
April 26, 2024
Tenax Therapeutics CEO Christopher Giordano's 2022 pay falls 22% to $667K
April 28, 2023
Tenax Therapeutics CEO Anthony DiTonno's 2021 pay jumps 44% to $1.1M
April 28, 2022
Tenax Therapeutics CEO Anthony DiTonno's 2019 pay falls 22% to $505K
April 29, 2020
Tenax Therapeutics CFO Michael Jebsen's 2018 pay jumps 44% to $856K
April 19, 2019
Tenax Therapeutics CEO Chris Stern's 2011 pay slips 18% to $470K
September 6, 2011
About Tenax Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address101 Glen Lennox Drive, Suite 300, Chapel Hill, North Carolina 27517
- Phone919-855-2100
- Fiscal year endDecember 31
- Former names
- OXYGEN BIOTHERAPEUTICS, INC.Until September 14, 2014
- SYNTHETIC BLOOD INTERNATIONAL INCUntil June 29, 2008
Source: SEC filings on September 27, 2024, April 28, 2023, April 28, 2022, April 29, 2020, April 19, 2019, April 20, 2018, August 17, 2015, August 12, 2014, August 1, 2012, and September 6, 2011.